Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marina Gómez-Llobell"'
Autor:
Marina Gómez-Llobell, María Martínez García, Carlos Serra Smith, Daniel Gómez Costas, Gillen Oarbeascoa Royuela, Diego Carbonell, Javier Anguita Velasco, Ana María Pérez Corral, Marjorie Pion, Veronica Astrid Pérez-Fernández, Isabel Fernández García, Mariana Bastos Oreiro, Paula Fernández-Caldas González, Ignacio Gómez-Centurión, Ana Alarcón, Eva Catalá, Diego Conde, Jorge Gayoso, Pablo Olmos, Carolina Martínez Laperche, Jose García-Domínguez, Yolanda Fernández, Rebeca Bailen, MI Kwon
Publikováno v:
HemaSphere, Vol 7, p e4915881 (2023)
Externí odkaz:
https://doaj.org/article/bdd88c7d68024b4c8cab12c8dc5eec9a
Autor:
Marina Gómez-Llobell, Andrés Peleteiro Raíndo, Jose Climent Medina, Ignacio Gómez Centurión, Adrián Mosquera Orgueira
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundExperience with immune checkpoint inhibitors (ICIs) in the treatment of acute myeloid leukemia (AML) is still limited and based on early clinical trials, with no reported randomized clinical data. In this study, we reviewed the available ev
Externí odkaz:
https://doaj.org/article/07cb54b021d04747aa020b37a948fd52
Autor:
José Luis Díez-Martín, Marina Gómez-Llobell, Reyes María Martín-Rojas, Patricia Font Lopez, Jon Badiola, Ana Pérez-Corral, Pablo Silva, Diego Carbonell, Ignacio Gómez-Centurión, Isabel Pérez-Sánchez, Ismael Buño, María Chicano, Gabriela Rodríguez-Macías, Javier Anguita, Carolina Martínez-Laperche, Mónica Ballesteros, Mi Kwon
Publikováno v:
Blood. 138:3382-3382
BACKGROUND The revised genetic risk classification established by the European Leukemia Net (ELN) in 2017 stratifies patients diagnosed with acute myeloid leukemia (AML) into 3 prognostic categories (favourable, intermediate, and adverse) based on cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3a0462cddb6a272f77d329a2b120cf8
https://doi.org/10.1182/blood-2021-153202
https://doi.org/10.1182/blood-2021-153202